Avalo Therapeutics
(NASDAQ:AVTX)
$14.1575
-0.8225[-5.49%]
At close: Apr 25
$14.1575
0[0.00%]
After Hours: 9:17AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Avalo Therapeutics Stock (NASDAQ:AVTX), Quotes and News Summary

Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.

Open$15.000
Close$15.940
Volume / Avg.78.226K / 659.977K
Day Range14.690 - 16.225
52 Wk Range3.950 - 1.130K
Market Cap$14.641M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
60
Short Interest
7.59%
Days to Cover1

Recent News

Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.
Vandana Singh
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Avi Kapoor
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of VirTra, Inc. (NASDAQ: VTSI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter results.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
1.6
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Avalo Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AVTX
GLTO

FAQ

Q

How do I buy Avalo Therapeutics (AVTX) stock?

A

You can purchase shares of Avalo Therapeutics (NASDAQ: AVTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avalo Therapeutics's (AVTX) competitors?

A

Other companies in Avalo Therapeutics’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Vaxxinity (NASDAQ:VAXX), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).

Q

What is the target price for Avalo Therapeutics (AVTX) stock?

A

The latest price target for Avalo Therapeutics (NASDAQ: AVTX) was reported by Oppenheimer on Tuesday, April 16, 2024. The analyst firm set a price target for 35.00 expecting AVTX to rise to within 12 months (a possible 147.22% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avalo Therapeutics (AVTX)?

A

The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $14.1575 last updated April 25, 2024 at 9:17 AM EDT.

Q

Does Avalo Therapeutics (AVTX) pay a dividend?

A

There are no upcoming dividends for Avalo Therapeutics.

Q

When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?

A

Avalo Therapeutics’s Q4 earnings are confirmed for Friday, May 10, 2024.

Q

Is Avalo Therapeutics (AVTX) going to split?

A

There is no upcoming split for Avalo Therapeutics.

Q

What sector and industry does Avalo Therapeutics (AVTX) operate in?

A

Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch